Teeth loss after teriflunomide treatment: Casual or causal? A short case series.
暂无分享,去创建一个
A. Lugaresi | A. Carotenuto | V. Brescia Morra | L. Mancinelli | V. Vacchiano | M. Piattelli | N. Frattaruolo | C. Scandellari | M. Foschi
[1] P. Santos-Moreno,et al. Is the Treatment with Biological or Non-biological DMARDS a Modifier of Periodontal Condition in Patients with Rheumatoid Arthritis? , 2017, Current rheumatology reviews.
[2] M. Costalonga,et al. The oral microbiome and the immunobiology of periodontal disease and caries. , 2014, Immunology letters.
[3] L. Kappos,et al. Pooled safety and tolerability data from four placebo-controlled teriflunomide studies and extensions. , 2016, Multiple sclerosis and related disorders.
[4] G. Hajishengallis. Immunomicrobial pathogenesis of periodontitis: keystones, pathobionts, and host response. , 2014, Trends in immunology.